NCT07538583 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome Status RECRUITING Phase PHASE2/PHASE3
NCT07280091 Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome Status NOT_YET_RECRUITING Phase N/A
NCT06953466 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome Status RECRUITING Phase PHASE2/PHASE3
NCT06539507 A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 Status RECRUITING Phase PHASE1
NCT06137157 Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome Status RECRUITING Phase PHASE1
NCT05979831 A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome Status TERMINATED Phase PHASE1/PHASE2
NCT05856526 A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome Status TERMINATED Phase PHASE2/PHASE3
NCT05789056 Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome Status RECRUITING Phase PHASE2/PHASE3
NCT05583669 A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05521438 Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05388903 A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05211830 A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT04244006 A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome Status UNKNOWN Phase PHASE2/PHASE3
NCT03417856 Defining the Skin and Blood Biomarkers of Ichthyosis Status ENROLLING_BY_INVITATION Phase N/A
NCT03041038 The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Status COMPLETED Phase PHASE2
NCT01428297 A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome Status COMPLETED Phase PHASE1